Laurus Labs Limited — Capital/Financing Update 2023

Oct 16, 2023

October 16, 2023

==> picture [452 x 75] intentionally omitted <==

ToThe Corporate Relations DepartmentBSE LimitedPhiroz Jeejeebhoy Towers, 25thFloor,Dalal StreetMumbai – 400001Code: 540222	ToThe Listing DepartmentNational Stock Exchange of India Limited,Exchange Plaza,Bandra Kurla Complex, Bandra (East)Mumbai – 400 051Code: LAURUSLABS

Sub: Update on acquisition of shares of Laurus Bio Private Limited

Ref: Our disclosure dated September 11, 2023 regarding signing of SPA with shareholders of Laurus Bio Private Limited

Dear Sirs,

This is in continuation of our disclosure dated September 11, 2023 regarding signing of SPAs with the shareholders of M/s. Laurus Bio Private Limited (“Laurus Bio”) for purchase of 37,641 equity shares through secondary purchase.

In this regard, we wish to update that the Company has completed the acquisition of 29,308 equity shares from Mr. Subramani Ramachandrappa, Promoter and Non-Executive Director and employees/ex-employees shareholders of Laurus Bio, today.

Balance equity shares shall be acquired soon once the Conditions Precedents with respect to these balance shareholders are complied with.

This is for your information and record.

Yours faithfully,

For Laurus Labs Limited Digitally signed by VENKATESWAR VENKATESWAR REDDY REDDY GOGIREDDY GOGIREDDY Date: 2023.10.16 19:14:26 +05'30' G. Venkateswar Reddy Company Secretary & Compliance Officer

==> picture [452 x 43] intentionally omitted <==